Neoantigen peptide vaccine: Clinical Trials

4 trials of Neoantigen peptide vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 terminated. 3 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Terminated 1
Not applicable1Recruiting 1
Phase 21Recruiting 1

Follow Neoantigen peptide vaccine: new trials by email Literature Review of Neoantigen peptide vaccine trials Research Report on Neoantigen peptide vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors
Neoantigen peptide vaccine, Neoantigen-based DC immune preparation - Advanced Malignant Solid Tumors
Not applicableRecruitingThe First Affiliated Hospital of Nanchang University202023-04-012025-02-27
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC - Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Phase 1RecruitingFred Hutchinson Cancer Center282022-06-092026-07-22
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic1382022-03-312026-08-20
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Neoantigen Peptide Vaccine, Poly ICLC, Blood for immune monitoring - Pancreas Cancer, Pancreatic Cancer
Phase 1TerminatedWashington University School of Medicine122020-02-132024-07-17

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Lung Neoplasms (2)  ·  Melanoma (2)  ·  Neoplasm Metastasis (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Lobular (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Endometrial Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  Mayo Clinic (1)  ·  The First Affiliated Hospital of Nanchang University (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  China (1)

Top investigators

Joshua Veatch (1)  ·  William E Gillanders, M.D. (1)  ·  Yanyan Lou, MD, PhD (1)

NIH funding

P50CA196510 (1)